ReveraGen BioPharma
Pre-clinicalDevelops dissociative steroidal therapeutics for rare neuromuscular and inflammatory diseases.
Founded
2008
Focus
Small Molecules
About
Develops dissociative steroidal therapeutics for rare neuromuscular and inflammatory diseases.
Funding History
3Total raised: $40M
Series B$25MUndisclosedMar 15, 2021
Series A$10MUndisclosedAug 15, 2018
Grant$5MNIHApr 15, 2016
Company Info
TypePrivate
Founded2008
LocationRockville, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile